Teva Announces Launch of a Generic Version of VESIcare (solifenacin succinate) Tablets in the United States Read more
Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis Read more
China based innovation, CDMOs and Parallel Approvals driving huge growth in manufacturing at CPhI China Read more